1622. Outcomes of Colistin Weight-Based Dosing Versus The Non-Weight-Based Dosing

BACKGROUND: The use of colistin is currently the mainstay antimicrobial for several multi-drug resistant organisms (MDROs). New guidelines were recently published recommending non-weight-based (NWB) dosing of colistin. There is limited data on outcomes with this new dosing strategy. The purpose of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Anouassi, Zohour, El Lababidi, Rania M, Salem, Nouran, El Nekidy, Wasim S, Mooty, Mohamad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776218/
http://dx.doi.org/10.1093/ofid/ofaa439.1802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776218/
http://dx.doi.org/10.1093/ofid/ofaa439.1802

Ejemplares similares